Drug Profile
Flupirtine-based pain therapy
Alternative Names: CNSB001; CNSB015Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator CNSBio
- Developer Relevare Pharmaceuticals
- Class Aminopyridines; Muscle relaxants; Non-opioid analgesics; Opiate alkaloids; Small molecules
- Mechanism of Action KCNQ potassium channel agonists; NMDA receptor antagonists; Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetic neuropathies; Neuropathic pain